vs
CXApp Inc.(CXAI)与Arcadia Biosciences, Inc.(RKDA)财务数据对比。点击上方公司名可切换其他公司
CXApp Inc.的季度营收约是Arcadia Biosciences, Inc.的1.1倍($1.0M vs $901.0K),Arcadia Biosciences, Inc.净利率更高(-148.3% vs -544.1%,领先395.8%),Arcadia Biosciences, Inc.同比增速更快(-25.8% vs -38.5%),过去两年Arcadia Biosciences, Inc.的营收复合增速更高(-4.5% vs -25.0%)
CXApp Inc.是一家专注于数字工作场所体验解决方案的科技企业,提供员工参与度提升、办公空间优化、访客管理、混合办公协调等云服务产品,主要服务北美、亚太、欧洲的中大型企业客户。
阿卡迪亚生物科学是一家美国上市农业生物技术企业,总部位于加利福尼亚州戴维斯,专注于开发可提升作物品质与产量的作物性状改良技术,该公司部分股权归道德指南针公司所有。
CXAI vs RKDA — 直观对比
营收规模更大
CXAI
是对方的1.1倍
$901.0K
营收增速更快
RKDA
高出12.6%
-38.5%
净利率更高
RKDA
高出395.8%
-544.1%
两年增速更快
RKDA
近两年复合增速
-25.0%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | ||
|---|---|---|
| 营收 | $1.0M | $901.0K |
| 净利润 | $-5.6M | $-1.3M |
| 毛利率 | 86.9% | 21.4% |
| 营业利润率 | -576.9% | -152.8% |
| 净利率 | -544.1% | -148.3% |
| 营收同比 | -38.5% | -25.8% |
| 净利润同比 | -56.7% | 67.1% |
| 每股收益(稀释后) | — | $-0.97 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比,按日历期对齐,财年错位的公司也能正确匹配
营收
CXAI
RKDA
| Q4 25 | $1.0M | $901.0K | ||
| Q3 25 | $1.1M | $1.3M | ||
| Q2 25 | $1.2M | $1.5M | ||
| Q1 25 | $1.2M | $1.2M | ||
| Q4 24 | $1.7M | $1.2M | ||
| Q3 24 | $1.9M | $1.5M | ||
| Q2 24 | $1.8M | $1.3M | ||
| Q1 24 | $1.8M | $987.0K |
净利润
CXAI
RKDA
| Q4 25 | $-5.6M | $-1.3M | ||
| Q3 25 | $-3.2M | $856.0K | ||
| Q2 25 | $-3.1M | $-4.5M | ||
| Q1 25 | $-1.6M | $2.6M | ||
| Q4 24 | $-3.5M | $-4.1M | ||
| Q3 24 | $-5.4M | $-1.6M | ||
| Q2 24 | $-5.3M | $1.1M | ||
| Q1 24 | $-5.2M | $-2.4M |
毛利率
CXAI
RKDA
| Q4 25 | 86.9% | 21.4% | ||
| Q3 25 | 89.0% | 32.1% | ||
| Q2 25 | 86.0% | 43.4% | ||
| Q1 25 | 87.7% | 43.2% | ||
| Q4 24 | 86.0% | 31.9% | ||
| Q3 24 | 80.4% | 32.9% | ||
| Q2 24 | 80.0% | 51.5% | ||
| Q1 24 | 82.0% | 52.3% |
营业利润率
CXAI
RKDA
| Q4 25 | -576.9% | -152.8% | ||
| Q3 25 | -343.4% | -88.5% | ||
| Q2 25 | -336.1% | -34.4% | ||
| Q1 25 | -306.0% | 44.2% | ||
| Q4 24 | -169.7% | -187.7% | ||
| Q3 24 | -194.3% | -114.5% | ||
| Q2 24 | -206.7% | — | ||
| Q1 24 | -197.3% | -160.9% |
净利率
CXAI
RKDA
| Q4 25 | -544.1% | -148.3% | ||
| Q3 25 | -283.4% | 65.7% | ||
| Q2 25 | -256.7% | -306.4% | ||
| Q1 25 | -132.0% | 216.6% | ||
| Q4 24 | -213.6% | -334.5% | ||
| Q3 24 | -286.5% | -104.9% | ||
| Q2 24 | -297.6% | 81.2% | ||
| Q1 24 | -284.4% | -245.5% |
每股收益(稀释后)
CXAI
RKDA
| Q4 25 | — | $-0.97 | ||
| Q3 25 | — | $0.62 | ||
| Q2 25 | — | $-3.26 | ||
| Q1 25 | — | $1.90 | ||
| Q4 24 | — | $-2.99 | ||
| Q3 24 | — | $-1.18 | ||
| Q2 24 | — | $0.78 | ||
| Q1 24 | — | $-1.78 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | ||
|---|---|---|
| 现金及短期投资手头流动性 | $11.1M | $4.6M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $14.0M | $4.1M |
| 总资产 | $32.4M | $6.5M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势,按日历期对齐
现金及短期投资
CXAI
RKDA
| Q4 25 | $11.1M | $4.6M | ||
| Q3 25 | $5.1M | $5.9M | ||
| Q2 25 | $4.9M | $4.4M | ||
| Q1 25 | $3.9M | $3.2M | ||
| Q4 24 | $4.9M | $4.2M | ||
| Q3 24 | — | $6.6M | ||
| Q2 24 | — | $8.1M | ||
| Q1 24 | — | $8.5M |
股东权益
CXAI
RKDA
| Q4 25 | $14.0M | $4.1M | ||
| Q3 25 | $15.2M | $5.4M | ||
| Q2 25 | $14.3M | $4.5M | ||
| Q1 25 | $15.6M | $8.9M | ||
| Q4 24 | $15.6M | $6.2M | ||
| Q3 24 | $13.6M | $10.3M | ||
| Q2 24 | $16.3M | $11.7M | ||
| Q1 24 | $20.9M | $10.6M |
总资产
CXAI
RKDA
| Q4 25 | $32.4M | $6.5M | ||
| Q3 25 | $28.5M | $8.6M | ||
| Q2 25 | $29.6M | $7.8M | ||
| Q1 25 | $29.3M | $13.0M | ||
| Q4 24 | $31.8M | $13.5M | ||
| Q3 24 | — | $15.2M | ||
| Q2 24 | — | $17.4M | ||
| Q1 24 | — | $16.0M |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | ||
|---|---|---|
| 经营现金流最新季度 | $-3.6M | $-861.0K |
| 自由现金流经营现金流 - 资本支出 | $-3.6M | — |
| 自由现金流率自由现金流/营收 | -355.5% | — |
| 资本支出强度资本支出/营收 | 0.2% | 0.0% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $-10.4M | — |
8季度趋势,按日历期对齐
经营现金流
CXAI
RKDA
| Q4 25 | $-3.6M | $-861.0K | ||
| Q3 25 | $-2.8M | $-257.0K | ||
| Q2 25 | $-3.0M | $-2.0M | ||
| Q1 25 | $-979.0K | $-1.6M | ||
| Q4 24 | $-2.7M | $-2.2M | ||
| Q3 24 | $-2.1M | $-1.8M | ||
| Q2 24 | $-1.9M | $-2.5M | ||
| Q1 24 | $-650.0K | $-3.2M |
自由现金流
CXAI
RKDA
| Q4 25 | $-3.6M | — | ||
| Q3 25 | $-2.8M | — | ||
| Q2 25 | $-3.0M | — | ||
| Q1 25 | $-984.0K | — | ||
| Q4 24 | — | — | ||
| Q3 24 | $-2.1M | — | ||
| Q2 24 | $-1.9M | $-2.5M | ||
| Q1 24 | $-668.0K | $-3.2M |
自由现金流率
CXAI
RKDA
| Q4 25 | -355.5% | — | ||
| Q3 25 | -248.1% | — | ||
| Q2 25 | -247.2% | — | ||
| Q1 25 | -80.4% | — | ||
| Q4 24 | — | — | ||
| Q3 24 | -109.3% | — | ||
| Q2 24 | -108.6% | -188.3% | ||
| Q1 24 | -36.7% | -326.5% |
资本支出强度
CXAI
RKDA
| Q4 25 | 0.2% | 0.0% | ||
| Q3 25 | 0.4% | 0.0% | ||
| Q2 25 | 0.9% | 0.0% | ||
| Q1 25 | 0.4% | 0.0% | ||
| Q4 24 | 0.0% | 0.0% | ||
| Q3 24 | 0.2% | 0.0% | ||
| Q2 24 | 0.5% | 0.2% | ||
| Q1 24 | 1.0% | 1.3% |
现金转化率
CXAI
RKDA
| Q4 25 | — | — | ||
| Q3 25 | — | -0.30× | ||
| Q2 25 | — | — | ||
| Q1 25 | — | -0.61× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | -2.31× | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图